CRESCENT BIOPHARMA INC.
CBIO·G2545C104·US·Common Stock·Healthcare - Biotechnology-Activist
CBIO (CRESCENT BIOPHARMA INC.) is held by 36 institutional investors as of Q1 2026. Largest holders: FMR LLC ($75.9M), BALYASNY ASSET MANAGEMENT L.P. ($27.7M), VANGUARD CAPITAL MANAGEMENT LLC ($14.7M). Net institutional sentiment: Bullish.
36
Holders
Avg rating(4 Elite)
$179.3M
Total Value
68% (43)
Fund Consensus
23 buying - 11 selling
Who's Trading
InsiderBTBrumm Joshua TSell $761KJun 22, 2026
InsiderMJMcNeill JonathanSell $370KJun 22, 2026
InsiderPJPinkas JanSell $23KJun 22, 2026
InsiderIEIm Ellie EunkyungSell $22KJun 22, 2026
InsiderSWScalzo Richard WilliamSell $20KJun 22, 2026
InsiderBHBispham Barbara HarlinSell $22KJun 22, 2026
InsiderLRLynch RyanSell $8KJun 22, 2026
ActivistTATANG CAPITAL MANAGEMENT, LLC4.2%May 15, 2026
ActivistVHVenrock Healthcare Capital Partners III, L.P.9.5%Feb 17, 2026
13F: Insider & Congress:
Showing 1-20 of 43
1 / 3
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer